Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Pregnant Women’s Perceptions of Harms and Benefits of Mental Health Screening

  • Dawn Kingston ,

    dawn.kingston@ualberta.ca

    Affiliation Faculty of Nursing, Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Alberta, Canada

  • Marie-Paule Austin,

    Affiliation St John of God Chair Perinatal & Women’s Mental Health, School of Psychiatry, University of New South Wales, Sydney, Australia

  • Sheila W. McDonald,

    Affiliation Population, Public, and Aboriginal Health, Alberta Health Services, Calgary, Alberta, Canada

  • Lydia Vermeyden,

    Affiliation Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada

  • Maureen Heaman,

    Affiliation College of Nursing, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada

  • Kathleen Hegadoren,

    Affiliation Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada

  • Gerri Lasiuk,

    Affiliation Faculty of Nursing, University of Saskatchewan, Regina, Saskatchewan, Canada

  • Joshua Kingston,

    Affiliation Faculty of Science (Computer Science), MacEwan University, Edmonton, Alberta, Canada

  • Wendy Sword,

    Affiliation School of Nursing, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada

  • Karly Jarema,

    Affiliation Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada

  • Sander Veldhuyzen van Zanten,

    Affiliation Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada

  • Sarah D. McDonald,

    Affiliation Division of Maternal-Fetal Medicine, Departments of Obstetrics & Gynecology, Radiology, and Clinical, Epidemiology & Biostatistics McMaster University, Hamilton, Ontario, Canada

  • Anne Biringer

    Affiliation Department of Family and Community Medicine, University of Toronto, Ada and Slaight Family Director of Maternity Care, Ray D Wolfe Department of Family Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

Pregnant Women’s Perceptions of Harms and Benefits of Mental Health Screening

  • Dawn Kingston, 
  • Marie-Paule Austin, 
  • Sheila W. McDonald, 
  • Lydia Vermeyden, 
  • Maureen Heaman, 
  • Kathleen Hegadoren, 
  • Gerri Lasiuk, 
  • Joshua Kingston, 
  • Wendy Sword, 
  • Karly Jarema
PLOS
x

Abstract

Background

A widely held concern of screening is that its psychological harms may outweigh the benefits of early detection and treatment. This study describes pregnant women's perceptions of possible harms and benefits of mental health screening and factors associated with identifying screening as harmful or beneficial.

Methods

This study analyzed a subgroup of women who had undergone formal or informal mental health screening from our larger multi-site, cross-sectional study. Pregnant women >16 years of age who spoke/read English were recruited (May-December 2013) from prenatal classes and maternity clinics in Alberta, Canada. Descriptive statistics were generated to summarize harms and benefits of screening and multivariable logistic regression identified factors associated with reporting at least one harm or affirming screening as a positive experience (January-December 2014).

Results

Overall study participation rate was 92% (N = 460/500). Among women screened for mental health concerns (n = 238), 63% viewed screening as positive, 69% were glad to be asked, and 87% took it as evidence their provider cared about them. Only one woman identified screening as a negative experience. Of the 6 harms, none was endorsed by >7% of women, with embarrassment being most cited. Women who were very comfortable (vs somewhat/not comfortable) with screening were more likely to report it as a positive experience.

Limitations

Women were largely Caucasian, well-educated, partnered women; thus, findings may not be generalizable to women with socioeconomic risk.

Conclusions

Most women perceived prenatal mental health screening as having high benefit and low harm. These findings dispel popular concerns that mental health screening is psychologically harmful.

Background

Despite rates that are similar to or exceed the most prevalent pregnancy-related complications screened for and treated during pregnancy [14], mental health is not comprehensively assessed as a component of routine prenatal care in Canada and the U.S. However, without early detection and treatment, the risk of chronicity is high. Recent epidemiologic evidence from two longitudinal birth cohorts suggests that 30–40% of women with prenatal depression continue to experience symptoms at 4 and 5 years postpartum [5,6]. In addition to highlighting the high rates of persistent depression beginning in pregnancy, these studies also revealed that chronic depression is associated with sub-optimal development in 19% of children of mothers with sub-clinical depressive symptoms and 24% of those whose mothers had clinical depressive symptoms (versus 7% in the ‘no depression’ group) [5]. Emerging findings from a small feasibility trial are promising in suggesting that antenatal psychological therapy may be effective for the reduction of antenatal anxiety symptoms, the rate of postpartum depression, and more optimal infant development outcomes, compared with the control group. [7] Thus, early identification and treatment of prenatal mental health problems may have substantial long-term benefits for maternal and child wellbeing.

A main barrier to early identification and subsequent treatment of prenatal mental health problems is the lack of routine prenatal mental health screening. While supported by international organizations [810], and most recently the American College of Obstetricians and Gynecologists [11], mental health screening has not been widely adopted within the context of mainstream prenatal care. One of the barriers to implementation is providers’ and policy-makers’ concern that a majority of women will experience psychological harm as a result of the screening process (e.g., stigma; false-positives). While a few qualitative studies suggest that some women have negative experiences during prenatal and postnatal mental health screening [12,13], other studies report general acceptability [1418], including among women with high depressive symptoms [16]. Indeed, existing evidence for acute and long-term psychological harm of screening is poor [19,20], and much of this research has been generated within the context of cancer screening [21,22]. Thus, there is a need for rigorous evidence concerning the relative benefits and harms of mental health screening during pregnancy. The purposes of this study were to describe pregnant women’s perceptions of the benefits and harms of mental health screening and factors associated with identifying screening as harmful or beneficial (including sociodemographics, previous mental health diagnoses, type of provider, and barriers to disclosure).

Methods

Study Design and Inclusion Criteria

For this cross-sectional, multi-site study, pregnant women were consecutively recruited between May and November, 2013 from the two community hospital-based prenatal classes and five maternity clinics in Alberta, Canada. Pregnant women were eligible if they: 1) were >16 years of age; and 2) could speak/read English. The recruitment sites served a socioeconomically diverse patient population. Recruitment and study procedures have been described previously [23]. Approval was granted by the University of Alberta Research Ethics Board.

Data Collection

Detailed description and development of the Barriers and Facilitators of Mental Health Screening Questionnaire have been reported previously [23]. Briefly, the 63-item self-report questionnaire was designed to identify barriers to and facilitators of screening and responses to mental health screening in pregnancy, including perceived harms and benefits. We have previously reported on results related to women’s acceptance of screening and preferences for method of screening [23] and barriers and facilitators of screening [24]. A computer tablet-based version of the questionnaire, built and tested by the Women’s and Children’s Health Research Institute (University of Alberta), was utilized for data collection. Once participants provided their written, informed consent and then submitted their responses to the survey, data were encrypted and transferred to the Faculty of Medicine and Dentistry at University of Alberta. All participants were 16+ years of age and gave written, informed consent electronically which the Research Ethics Board of the University of Alberta approved for consent procedure.

Main Outcomes

The main outcomes of this sub-analysis were women’s perceptions of the benefits and harms of mental health screening during pregnancy. A statement introducing the list of harms (n = 6) and benefits (n = 3) indicated, “There are many different ways that care providers may use to ask you about your emotional health (e.g., your mood or anxiety) during pregnancy…..How would you describe your experience of being asked about your emotional health?” and asked women to respond ‘yes’ or ‘no’ to each specific statement of benefit or harm. Specific benefits that we assessed were: felt provider cared; glad to be asked; and was a positive experience. Items related to harms were: felt embarrassed; did not know why my provider asked certain questions; was a negative experience; felt worried about what would happen with my information; the way questions were asked made me uncomfortable; and the questions made me uncomfortable.

Sample Size Estimation and Analysis

This study utilized the sub-set of participants from the larger multi-site, cross-sectional study who indicated that their provider had formally (e.g., using a screening tool) or informally (e.g., verbal inquiry) screened them for mental health concerns during pregnancy (n = 238). Sample size estimation was based on the intent to use multivariable regression to identify factors associated with harms and benefits (100 + 8m, where m = number of predictors) [25]. We conservatively estimated 15 independent variables, thus requiring a minimum sample size of 220.

Descriptive statistics (proportions, means, standard deviations) were generated. For the multivariable logistic regression analysis of factors associated with perceived harms, we constructed the outcome variable ‘identified one or more harms of screening’ because fewer than 7% of women endorsed any single harm. For the model describing factors associated with benefits of screening, we used women’s overall assessment, ‘It was a positive experience’ (yes versus no) as the outcome. We could not use the item, ‘It was a negative experience’ (yes versus no) as originally planned, because only one woman responded affirmatively. We estimated unadjusted odds ratios for the association between each independent variable and outcome. In particular, we were interested in associations between the outcomes and demographic variables, previous diagnosis or treatment for a mental health problem, type of provider, comfort with the screening process, two stigma-related factors (worry about being seen as a bad mother; not wanting to be seen by provider as anxious or depressed), and six perceived barriers to screening (e.g., worry that provider would not think mental health concerns were important; provider does not have time to talk; I feel I could handle mental health problems on my own; significant other has told me my emotions are normal for pregnancy and not to worry; worry about being put on antidepressants; would rather discuss emotional concerns with significant others). Variables associated with outcomes at p<0.20 were included in the multivariable logistic regression analyses with statistical significance for final models set at p<.05. All variables were adjusted for each other. Correlations among independent variables that met criteria for model entry were generated to assess for multicollinearity (r>0.4). Adjusted odds ratios and 95% confidence intervals were calculated. Statistical analyses were conducted using SPSS version 21 (SPSS IBM, New York, USA). Missing data were minimized by using the online questionnaire that required women to respond before proceeding to subsequent questions. All analyses were conducted January-December 2014.

Results

The overall study participation rate was 92% (N = 460/500). Of the 238 women in the larger sample who had been formally or informally screened for mental health concerns (51.7%; 238/460), over 80% were ≥25 years of age (M = 29.0, SD 4.4), had some or completed post-secondary education, and were Caucasian (Table 1). Mean gestational age was 30 weeks (SD 5.4). One-quarter of women had previously been diagnosed with a mental health problem. No significant differences were found between the sub-group of women who had been screened and the overall sample (data not shown).

thumbnail
Table 1. Sample characteristics of pregnant women responding to Barriers and Facilitators of Mental Health Screening Questionnaire in Alberta, Canada (N = 238).

http://dx.doi.org/10.1371/journal.pone.0145189.t001

In response to the question, ‘How would you describe the experience of being asked about your mental health’, 63% percent of women indicated ‘It was positive’ with one woman reporting ‘It was negative’ (Table 2). Over three-quarters of women (78%) indicated that a benefit of screening was that it made them feel their provider cared about them and 69% felt glad to be asked. Seventeen percent (n = 40) of the sample identified at least one harm and 2% (n = 5) reported 2 or more. Each of the harms related to screening that we assessed (Table 2) was endorsed by less than 7% of women. The most common harm identified was feeling embarrassed (n = 16, 6.7%) (Table 2).

thumbnail
Table 2. Description of responses to screening identified by pregnant women who underwent prenatal mental health screening in the Barriers and Facilitators of Mental Health Screening Questionnaire in Alberta, Canada (N = 238).

http://dx.doi.org/10.1371/journal.pone.0145189.t002

Benefits of screening

In the multivariable model examining factors associated with identifying screening as a positive experience (Table 3), the only significant finding was that women who were very comfortable with mental health screening (85.3%) had over twice the odds of reporting screening as positive (AOR 2.43, 95% CI 1.18–4.98), compared with those who were somewhat or not at all comfortable with screening (14.7%).

thumbnail
Table 3. Factors associated with reporting mental health screening as a positive experience among pregnant women who had undergone mental health screening in Alberta, Canada (as reported in the Barriers and Facilitators of Mental Health Screening Questionnaire) (N = 238).

http://dx.doi.org/10.1371/journal.pone.0145189.t003

Harms of screening

In the multivariable model with the outcome ‘identified one or more harms of screening’, no variables that we assessed were significant, including demographics, type of provider, barriers or stigma-related factors (Table 4). While a previous diagnosis of a mental health problem was significantly related to identifying at least one harm of screening in the univariable analysis (37.5% vs 21.8%), it was not significant in the multivariable model.

thumbnail
Table 4. Factors associated with identifying one or more harms of mental health screening among pregnant women who had undergone mental health screening in Alberta, Canada (as reported in the Barriers and Facilitators of Mental Health Screening Questionnaire) (N = 238).

http://dx.doi.org/10.1371/journal.pone.0145189.t004

Because the most common harm identified by women was feeling embarrassed, we sought to understand what characterized women who reported feeling embarrassed during screening. No variables had statistically significant associations, including demographics, history of diagnosis or treatment, type of provider, barriers of screening or either of the ‘stigma’ variables (worry I would be seen as a bad mother would not want to be seen as depressed or anxious by provider) (data not shown).

Discussion

The current study reports on pregnant women’s perceived harms and benefits of mental health screening. To our knowledge, it is the first study to report quantitative data regarding harms and benefits of prenatal mental health screening. The majority of women identified screening as beneficial and reported that it made them feel that their provider cared. Only one woman reported that her experience of screening was negative. Each harm of screening that we assessed was endorsed by less than 7% of women, with the most common harm identified as feeling embarrassed. Demographics, type of provider, barriers and stigma-related factors were not related to benefits or harms of screening. Women who were very comfortable with mental health screening were more likely to identify screening as positive compared with those who were somewhat or not at all comfortable. No factors that we assessed were associated with endorsing one or more harms of screening.

The view of screening as a positive experience held by most women in this study stands in contrast to the perceptions held by some prenatal care providers that women view screening negatively [26]. While prenatal care providers cite women’s negative responses to screening as deterrents to implementing routine screening, including women’s unwillingness to discuss mental health, accept medication, receive counseling, or accept diagnoses [2730], our findings do not support clinicians’ and policymakers’ perceptions of women’s views of screening as harmful. A more broadly held concern of screening and an argument that is frequently used against screening (albeit with minimal evidence) is the potential psychological harm that is inflicted on the patient through screening, including false-positive results [31]. However, the high proportion of women who report screening as a positive experience and the low proportion that report it as negative (<1%) or harmful (<7%) does not support this presupposition. Moreover, women’s responses in this study suggest that they were glad to be asked about their mental health, identifying a key benefit as enhancement of the provider-patient relationship. Reid et al. (1998) also reported that women felt that routine psychosocial screening promoted a closer relationship with their providers, allowing them to share ‘uncomfortable things’ [32].

Indeed, interest is growing in consumer perceptions of the relative benefits and harms of screening—more so in cancer care than mental health care. Recent studies exploring benefits of screening for cancer versus harms (when conceptualized as false-positives) report that 97% of women find the benefits of cancer screening outweigh the harms [33], that false-positive cancer screening results are not associated with significant psychological distress up to 3-years post-screening [19], and that tolerance for false-positive (i.e., overdetection) is high when weighed against the risk of non-detection [20]. Furthermore, pregnant women who participated in qualitative interviews conducted in follow-up to this study’s Barriers and Facilitators questionnaire (n = 50) indicated that they perceived the benefits of mental health screening during pregnancy as greater than the potential harms, even if it meant that they had a false-positive screen. These women agreed that they would prefer to have a false-positive result (i.e., screened as positive and then later told that they did not have depression/anxiety) than a false-negative result that called their concerns and suspicions about having a mental health problem into question (i.e., they suspected they had a problem but were told on screening that they did not).

Benefit of Screening

Our findings revealed that demographic characteristics, being diagnosed or treated with a mental health problem, type of provider, barriers and stigma-related factors were not related to whether women viewed screening as a positive experience or not. This encouraging finding suggests that women universally view screening positively. The only factor associated with viewing screening as a positive experience or not was women’s comfort level with screening. In a previous study, we identified that the main contributor to women’s comfort with screening was whether they felt that they could be honest in disclosing mental health concerns with their provider [23]. Our previous research also suggests that pregnant women are most comfortable with screening when providers initiate the process (e.g., through routine prenatal mental health screening vs non-routine), and when more anonymous modes of screening are used (e.g., paper- and computer-based screening vs self-initiated face-to-face or telephone) [23]. Others have identified women’s lack of comfort as a deterrent to screening and suggest that comfort is more related to provider-oriented characteristics than to environmental factors [30]. Indeed, this research suggests that women are generally prepared and willing to disclose their mental health concerns. However, relational discomfort and providers’ deliberate decision not to facilitate disclosure of symptoms has potential to shift women’s conscious decision to one of non-disclosure [30]. As such, creating comfort by employing key low-resource strategies, such as establishing a relationship of trust, being aware of and eliminating stigmatizing behaviours (e.g., minimizing concerns) and using basic relationship skills (e.g., eye contact; listening) [30], are powerful approaches for optimizing the screening process and early detection. Indeed, as reported in this study by 78% of women, screening made them feel that their provider cared and in other studies [32], the very act of screening can have positive, ancillary benefits on the provider-patient relationship.

Harms of Screening

The lack of association with demographic factors, being diagnosed or treated with a mental health problem, barriers or stigma-related factors and identifying harms of screening is reassuring in that no specific subgroups of women perceived screening as harmful or identified the most common harm of feeling embarrassed during screening. The stigma-related variables (worry what provider would think; worry about being seen as a bad mother) also were unrelated to embarrassment in both unadjusted and adjusted models (data not shown), which suggests that embarrassment in screening may not be due to stigma. Facilitators of screening (e.g., provider was sensitive and interested, knew that talking about mental health was a part of normal prenatal care, reassurance that other pregnant women have emotional problems) were also unrelated to whether women identified a harm of screening as embarrassment or not. Thus, while in a few qualitative studies some women have identified harms of screening (uncomfortable, intrusive) [13], our data suggest that this is the experience of a minority of women.

Limitations

Over 80% of women in this sample were socioeconomically advantaged and Caucasian. Thus, while our findings did not reveal that less disadvantaged or non-Caucasian women perceived harms and benefits differently, this study should be replicated among vulnerable women, including sociodemographically disadvantaged and minority women. The findings related to harms of screening must be interpreted with caution because the number of women that identified harms (n = 40) and being embarrassed (n = 16) was low and this analysis may have been underpowered to detect an association. However, the number of variables that met criteria for entry into the final multivariable models for harms (n = 5) and embarrassment (n = 2) also was small but was within parameters for detecting significant associations if they existed at a power of 80%. Finally, although we asked whether women had “ever” been diagnosed or treated for depression, anxiety or any other form of emotional concern, we did not expressly ask women whether they currently suffered with these conditions.

Conclusion

A central argument in the debate against screening is the concern that the harms exceed the benefits of screening. While this widely held position is founded on little evidence, results from this multisite study provide empiric evidence that the majority of pregnant women view screening as having high benefit and low harm. The finding that no demographic variables (including previous history of diagnosis or treatment for mental health problems) were associated with identifying harm in screening is positive in that it suggests that this view is not held by specific sub-groups of women. Thus, these findings may alleviate clinicians’ and policy-makers’ concerns regarding the negative impact of mental health screening on pregnant women.

Acknowledgments

We would like to thank Pam Marples and Rick Watts of the WCHRI Clinical Research Informatics team for constructing the web-based surveys and managing data security.

Author Contributions

Conceived and designed the experiments: DK AB GL KH MH SWM SDM SVvZ MPA WS. Performed the experiments: JK KJ. Analyzed the data: DK JK LV. Wrote the paper: DK. Critically reviewed the manuscript and approved the final version: DK MPA SWM LV MH KH GL JK WS KJ SVvZ SDM AB. Contributed to data interpretation: DK MPA SWM LV MH KH GL JK WS KJ SVvZ SDM AB.

References

  1. 1. Mayo K, Melamed N, Vandenberghe H, Berger H. The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. Am J Obstet Gynecol. 2015; 212: 224 e221–229.
  2. 2. Hooper DE. Detecting GD and preeclampsia. Effectiveness of routine urine screening for glucose and protein. J Reprod Med. 1996;41: 885–888. pmid:8979200
  3. 3. Kapadia MZ, Gaston A, Van Blyderveen S, Schmidt L, Beyene J, McDonald H et al. Psychological antecedents of excess gestational weight gain: a systematic review. BMC Pregnancy Childbirth. 2015;15: 107. doi: 10.1186/s12884-015-0535-y. pmid:25933604
  4. 4. Pare E, Parry S, McElrath TF, Pucci D, Newton A, Lim KH et al. Clinical risk factors for preeclampsia in the 21st century. Obstet Gynecol. 2014;124: 763–770. doi: 10.1097/AOG.0000000000000451. pmid:25198274
  5. 5. Giallo R, Woolhouse H, Gartland D, Hiscock H, Brown S. The emotional-behavioural functioning of children exposed to maternal depressive symptoms across pregnancy and early childhood: a prospective Australian pregnancy cohort study. Eur Child Adolesc Psychiatry. 2015.
  6. 6. van der Waerden J, Galera C, Saurel-Cubizolles MJ, Sutter-Dallay AL, Melchior M, and the EDEN Mother- Child Cohort Study Group. Predictors of persistent maternal depression trajectories in early childhood: results from the EDEN mother-child cohort study in France. Psychol Med. 2015;1–14.
  7. 7. Milgrom J, Gemmill A. Feasibility and efficacy of an internet treatment for postnatal depression utilising a behavioural activation approach. Evid Based Nurs. 2014.
  8. 8. Austin MP, Marce Society Position Statement Advisory Committee (2014) Marce International Society position statement on psychosocial assessment and depression screening in perinatal women. Best Pract Res Clin Obstet Gynaecol. 2014;28: 179–187. doi: 10.1016/j.bpobgyn.2013.08.016. pmid:24138943
  9. 9. NICE. Antenatal and postnatal mental health: Clinical management and service guidance. UK: National Institute for Health and Care Excellence; 2014,192.
  10. 10. Austin MP, Highet N. and the Guidelines Expert Advisory Committee. Clinical practice guidelines for depression and related disorders—anxiety, bipolar disorder and puerperal psychosis—in the perinatal period. A guideline for primary care health professionals. Melbourne: Beyond Blue; 2011.
  11. 11. American College of Obstetricians and Gynecologists. Committee opinion no. 631: screening for perinatal depression. Obstet Gynecol. 2015;125: 1268–1271. pmid:25932866
  12. 12. Shakespeare J, Blake F, Garcia J. A qualitative study of the acceptability of routine screening of postnatal women using the Edinburgh Postnatal Depression Scale. Br J Gen Pract. 2003;53: 614–619. pmid:14601337
  13. 13. Rollans M, Schmied V, Kemp L, Meade T. Digging over that old ground: an Australian perspective of women's experience of psychosocial assessment and depression screening in pregnancy and following birth. BMC Womens Health. 2013;13: 18. doi: 10.1186/1472-6874-13-18. pmid:23570282
  14. 14. Matthey S, White T, Phillips J, Taouk R, Chee TT, Barnett B. Acceptability of routine antenatal psychosocial assessments to women from English and non-English speaking backgrounds. Arch Womens Ment Health. 2005;8: 171–180. pmid:15915317
  15. 15. Leigh B, Milgrom J. Acceptability of antenatal screening for depression in routine antenatal care. Aust J Adv Nurs. 2007;4: 14–18.
  16. 16. Gemmill AW, Leigh B, Ericksen J, Milgrom J. A survey of the clinical acceptability of screening for postnatal depression in depressed and non-depressed women. BMC Public Health. 2006;6: 211. pmid:16914061
  17. 17. Buist A, Condon J, Brooks J, Speelman C, Milgrom J, Hayes B, et al. Acceptability of routine screening for perinatal depression. J Affect Disord. 2006;93: 233–237. pmid:16647761
  18. 18. Austin MP, Colton J, Priest S, Reilly N, Hadzi-Pavlovic D. The antenatal risk questionnaire (ANRQ): acceptability and use for psychosocial risk assessment in the maternity setting. Women Birth. 2013;26: 17–25. pmid:21764399
  19. 19. Bond M, Pavey T, Welch K, Cooper C, Garside R, Dean S, et al. Systematic review of the psychological consequences of false-positive screening mammograms. Health Technol Assess. 2013;17: 1–170, v–vi.
  20. 20. Van den Bruel A, Jones C, Yang Y, Oke J, Hewitson P. People's willingness to accept overdetection in cancer screening: population survey. BMJ. 2015; 350: h980. doi: 10.1136/bmj.h980. pmid:25736617
  21. 21. Independent U. K. Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380: 1778–1786. doi: 10.1016/S0140-6736(12)61611-0. pmid:23117178
  22. 22. Amir E, Bedard PL, Ocana A, Seruga B. Benefits and harms of detecting clinically occult breast cancer. J Natl Cancer Inst. 2012;104: 1542–1547. doi: 10.1093/jnci/djs394. pmid:22988040
  23. 23. Kingston D, Biringer A, McDonald S, Heaman M, Lasiuk G, Hegadoren K, et al. Preferences of screening among pregnant women: a cross-sectional study. Am J Prev Med, 2015: in press.
  24. 24. Kingston D, Austin M-P, Heaman M, McDonald S, Lasiuk G, Sword W, et al Barriers and facilitators of mental health screening in pregnancy. J Affect Disord, 2015: under review.
  25. 25. Sb Green. How many subjects does it take to do a regression analysis? Multivariate Behav Res. 1991;26: 499–510.
  26. 26. LaRocco-Cockburn A, Melville J, Bell M, Katon W. Depression screening attitudes and practices among obstetrician-gynecologists. Obstet Gynecol. 2003;101: 892–898. pmid:12738146
  27. 27. Bowen A, Bowen R, Butt P, Rahman K, Muhajarine N. Patterns of depression and treatment in pregnant and postpartum women. Can J Psychiatry. 2012;57: 161–167. pmid:22398002
  28. 28. Clatworthy J. The effectiveness of antenatal interventions to prevent postnatal depression in high-risk women. J Affect Disord. 2012;137: 25–34. doi: 10.1016/j.jad.2011.02.029. pmid:21514960
  29. 29. Leddy M, Haaga D, Gray J, Schulkin J. Postpartum mental health screening and diagnosis by obstetrician-gynecologists. J Psychosom Obstet Gynaecol 2011;32: 27–34. doi: 10.3109/0167482X.2010.547639. pmid:21261561
  30. 30. Chew-Graham CA, Sharp D, Chamberlain E, Folkes L, Turner KM. Disclosure of symptoms of postnatal depression, the perspectives of health professionals and women: a qualitative study. BMC Fam Pract. 2009;10: 7. doi: 10.1186/1471-2296-10-7. pmid:19159478
  31. 31. Canadian Task Force on Preventive Health Care, Joffres M, Jaramillo A, Dickinson J, Lewin G, Pottie K, et al. Recommendations on screening for depression in adults. CMAJ. 2013;185: 775–782. doi: 10.1503/cmaj.130403. pmid:23670157
  32. 32. Reid AJ, Biringer A, Carroll JD, Midmer D, Wilson LM, Chalmers B, et al. Using the ALPHA form in practice to assess antenatal psychosocial health. Antenatal Psychosocial Health Assessment. CMAJ. 1998;159: 677–684. pmid:9780969
  33. 33. Holman LL, Lu KH, Bast RC Jr., Hernandez MA, Bodurka DC, et al. Risk perception, worry, and test acceptance in average-risk women who undergo ovarian cancer screening. Am J Obstet Gynecol. 2014; 210: 257 e251–256.